Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Non-Hodgkin × Single Person × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lymphoma, Non-Hodgkin 1 Gastroesophageal Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 27 fludarabine 20 Rituximab 13 fludarabine phosphate 10 obinutuzumab 8 venetoclax 7 Lenalidomide 7 ibrutinib 6 Immunotherapy, Adoptive 6 Etoposide 6 pirtobrutinib 5 glofitamab 5 axicabtagene ciloleucel 5 Prednisone 5 polatuzumab vedotin 4 Specimen Handling 4 Doxorubicin 4 daratumumab 3 Whole-Body Irradiation 3 Vincristine 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Melphalan 3 Biopsy 3 tucatinib 2 tocilizumab 2 temsirolimus 2 relmacabtagene autoleucel 2 pomalidomide 2 pertuzumab 2 pembrolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008691 2025-12-29

FIL_MAB

Fondazione Italiana Linfomi - ETS

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡